
Sandra Cuellar, PharmD, BCOP, is the coordinator/professor for the oncology therapeutics course at the University of Illinois at Chicago (UIC) College of Pharmacy and an oncology clinical pharmacist at UI Health. Dr. Cuellar is also the director of the UIC oncology specialty residency program, a member of the Data and Safety Monitoring Committee (DSMC), and the vice-chair of institutional review board at UIC. She is involved in research, consulting, and publications in the field of hematology/oncology, and she is an editor-at-large for Journal of Hematology Oncology Pharmacy.
Dr. Cuellar has given multiple national and international presentations on cardio-oncology, supportive care oncology, biosimilars, and oncology therapeutics. She serves as an American Society of Health-System Pharmacists (ASHP) oncology residency surveyor and as chair of the Industry Relation Council for the Hematology Oncology Pharmacy Association.
Dr. Cuellar received her PharmD degree from the University of Illinois at Chicago College of Pharmacy, and she completed a pharmacy practice residency at the University of Kentucky Chandler Medical Center. She completed a specialty oncology residency at MD Anderson Cancer Center in Houston, Texas. Dr. Cuellar has been a board-certified oncology pharmacist since 2006, and she has been active in the field of hematology/oncology for 18 years.

Joanne Mortimer, MD, FACP, is a professor in and the vice chair of the Department of Medical Oncology at the City of Hope, and she is the director of the Women’s Cancers Program. Dr. Mortimer has conducted clinical trials in breast cancer for more than 25 years. Her research focuses on assessing the effects of systemic therapies on cancer and normal tissues.

Andrea Rodriguez, FNP-C, AOCNP, is an oncology certified nurse practitioner who contributes to research efforts at the University of Pittsburgh School of Nursing by focusing on disparities in breast cancer care. Rodriguez has 10 years of experience as a bedside nurse in oncology, and she has been a nurse practitioner for four years. Her work has been published in the Journal of Advanced Practice Providers in Oncology under the surname Fehl. Rodriguez is a member of the Oncology Nursing Society, The American Association of Nurse Practitioners, and the Advanced Practitioner Society for Hematology and Oncology. She contributes to the Advanced Oncology Certified Nurse Practitioner Practice Test Committee. Currently, Rodriguez is in a post-master’s certificate program in healthcare informatics at Chatham University.


This educational activity is supported by educational grants from AstraZeneca Pharmaceuticals and Daiichi Sankyo